Finasteride

Preview FDA label, Aurobindo Pharma Limited, oral, effective 2026-07-31. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Renal Impairment No dosage adjustment is necessary in patients with renal impairment [see Clinical Pharmacology ] .

Dosing in liver impairment

Hepatic Impairment Caution should be exercised in the administration of finasteride in those patients with liver function abnormalities, as finasteride is metabolized extensively in the liver [see Clinical Pharmacology ].